Universidad de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2020

  1. Novel population pharmacokinetic model for linezolid in critically ill patients and evaluation of the adequacy of the current dosing recommendation

    Pharmaceutics, Vol. 12, Núm. 1

2018

  1. Population pharmacokinetics of daptomycin in critically ill patients

    International Journal of Antimicrobial Agents, Vol. 52, Núm. 2, pp. 158-165

2014

  1. Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: Application to pharmacokinetic/pharmacodynamic analysis

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 1, pp. 180-189

  2. Response to circulatory death determination in uncontrolled organ donors: A panel viewpoint

    Annals of Emergency Medicine

2012

  1. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065

2010

  1. Endotoxin adsortion as adjuvant therapy in gramnegative severe sepsis

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 3, pp. 115-121

2008

  1. Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy

    Clinical Pharmacokinetics, Vol. 47, Núm. 3, pp. 173-180